GDRX (GoodRx Holdings) LT-Debt-to-Total-Asset: 0.26 (As of Mar. 2026)

What is GoodRx Holdings LT-Debt-to-Total-Asset?

GoodRx Holdings GDRX -0.33% 65 LT-Debt-to-Total-Asset is 0.26 as of Mar. 2026. GuruFocus rates GDRX with a GF Score™ of 65/100 and a GF Value™ of $5.66 (Possible Value Trap). The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. GoodRx Holdings's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.26.

GoodRx Holdings's long-term debt to total assets ratio declined from Mar. 2025 (0.41) to Mar. 2026 (0.26). It may suggest that GoodRx Holdings is progressively becoming less dependent on debt to grow their business.

GoodRx Holdings (NAS:GDRX) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

GoodRx Holdings LT-Debt-to-Total-Asset Related Terms

GoodRx Holdings LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for GoodRx Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GoodRx Holdings LT-Debt-to-Total-Asset Chart

GoodRx Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.43

0.44

0.38

GoodRx Holdings Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.41	0.41	0.40	0.38	0.26

65GF Score

GoodRx Holdings Inc GDRX

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

GoodRx Holdings LT-Debt-to-Total-Asset Calculation

GoodRx Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	533.053	/	1404.058
	=	0.38

GoodRx Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	531.375	/	2021.251
	=	0.26

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.26 mean?

GoodRx Holdings (GDRX) has a LT-Debt-to-Total-Asset of 0.26 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on GoodRx Holdings and its competitors.

Is GoodRx Holdings' LT-Debt-to-Total-Asset too high?

GoodRx Holdings' current LT-Debt-to-Total-Asset is 0.26. Overall, GoodRx Holdings has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does GoodRx Holdings' LT-Debt-to-Total-Asset compare to CERT and TALK?

GoodRx Holdings' LT-Debt-to-Total-Asset of 0.26 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Healthcare Providers & Services company?

A good LT-Debt-to-Total-Asset depends on the Healthcare Providers & Services industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on GoodRx Holdings and its competitors. GoodRx Holdings's current LT-Debt-to-Total-Asset is 0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is GoodRx Holdings stock overvalued right now?

Based on GuruFocus' analysis, GoodRx Holdings (GDRX) is currently considered Possible Value Trap. The stock's GF Value™ is $5.66, compared to a current price of $3.05 — trading 46.1% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.26. GoodRx Holdings' overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For GoodRx Holdings (GDRX), the current LT-Debt-to-Total-Asset is 0.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GoodRx Holdings (GDRX) Overvalued in 2026?

Based on GuruFocus' analysis, GoodRx Holdings stock appears to be undervalued. The current stock price of $3.05 is trading 46.1% below its estimated GF Value™ of $5.66. GuruFocus considers GoodRx Holdings to be Possible Value Trap.

Key valuation signals for GDRX:

LT-Debt-to-Total-Asset: 0.26
GF Value™: $5.66 vs. price of $3.05 (46.1% below fair value)
GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the GDRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GoodRx Holdings Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies CERT TALK HSTM OMDA SDGR PHR EVH CTEV MDRX SOPH VEEV ASX:PME BTSG TEM HQY TSE:2413 HNGE TXG DOCS WAY

Other Exchanges 8GH:Germany

Address 2701 Olympic Boulevard, Santa Monica, CA, USA, 90404

Website https://www.goodrx.com

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

65GF Score

Get the complete analysis for GDRX

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.05

Price

$5.66

GF Value

View GDRX Analysis

See LT-Debt-to-Total-Asset data for all stocks →